Radian Announces Second Quarter 2026 Financial Results

Radian Group reported Q2 2026 net income from continuing operations of $118 million, or $0.87/diluted share, down from $154 million, or $1.11/diluted share, a year earlier. Pretax income fell to $151 million from $193 million. Overall, the quarter shows profitability deterioration versus the prior year, which may pressure expectations going forward.

Analysis

This reads more like a normalization check than a thesis-breaker, but the market will still key off whether the decline reflects underwriting drift, lower float/portfolio income, or simply fewer one-time benefits. For mortgage insurers, the real driver is not one quarter’s EPS; it is whether ROE stays comfortably above cost of equity and whether book value per share keeps compounding. If this quarter signals softer profitability without a corresponding improvement in capital return, RDN’s multiple can compress first, and peers such as ESNT, MTG, and NMIH can get dragged in sympathy even if their fundamentals are cleaner.

The second-order read is that a weaker quarter at a private MI name can be a proxy for housing-finance softness: if origination volume is still muted, competition for new insurance written can intensify and pricing discipline can erode. That is usually a 1-3 month estimate-revision story, not an immediate balance-sheet problem. The contrarian view is that the market may be over-penalizing a cyclical earnings dip in a business where credit remains the swing factor; if delinquency trends stay benign, lower current earnings can coexist with intact intrinsic value and capital returns over 6-18 months.

What would falsify a negative view is confirmation on the call that book value growth and new business margins remain stable despite lower pretax income. If management guides to a sustained ROE reset below peer average, the de-rating risk becomes real and likely persists through the next few quarters. Until then, this is more of a relative-value watch item than a standalone short.

Key Decisions for Investors

• No immediate outright short in RDN; wait for the earnings call and guidance on ROE/book value before expressing a directional view. Falsify the cautious thesis if management reiterates stable mid-teens ROE and book value growth over the next quarter.
• If the stock sells off materially on the print, consider a tactical long RDN vs short ESNT or MTG only if the call confirms the issue is company-specific rather than industry-wide; target 1-3 month relative-reversion, stop if peer guidance deteriorates too.
• Set an alert on RDN price relative to tangible book value: if the discount widens beyond recent history without a corresponding deterioration in credit metrics, the risk/reward shifts toward a valuation bounce trade; if guidance implies lower normalized ROE, avoid the dip.
• Use the next 1-2 earnings cycles as the catalyst window; if pretax income remains weak while buybacks slow, expect further multiple compression across private MI names.